Pfizer Files 2023 Proxy Statement: Executive Compensation Details

Ticker: PFE · Form: DEF 14A · Filed: 2024-03-14T00:00:00.000Z

Sentiment: neutral

Topics: proxy-statement, executive-compensation, shareholder-meeting

Related Tickers: PFE

TL;DR

Pfizer's proxy statement is out, detailing exec pay for 2023. Shareholders vote soon.

AI Summary

Pfizer Inc. filed its DEF 14A proxy statement on March 14, 2024, for the fiscal year ending December 31, 2023. The filing details executive compensation, including stock and option awards, changes in pension value, and other equity awards granted in 2023 and prior years. The company's principal executive offices are located at 66 Hudson Boulevard East, New York, NY 10001.

Why It Matters

This filing provides shareholders with crucial information regarding how executive compensation is structured and awarded, impacting corporate governance and investor decisions.

Risk Assessment

Risk Level: low — This is a routine annual filing (DEF 14A) detailing executive compensation and shareholder matters, not indicating new or unusual risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of a DEF 14A filing?

A DEF 14A filing, also known as a Proxy Statement, is used to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.

When is Pfizer's fiscal year end?

Pfizer's fiscal year ends on December 31st, as indicated by the filing for the period ending 1231.

What specific compensation elements are detailed for executives in this filing?

The filing details elements such as Stock And Option Awards, Change In Pension Value, and Equity Awards Granted During The Year and in Prior Years.

Who is the filer of this document?

The filer is Pfizer Inc., identified by Central Index Key 0000078003.

What is the filing date of this DEF 14A?

This DEF 14A filing was made on March 14, 2024.

From the Filing

0000078003-24-000068.txt : 20240314 0000078003-24-000068.hdr.sgml : 20240314 20240314090308 ACCESSION NUMBER: 0000078003-24-000068 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 78 CONFORMED PERIOD OF REPORT: 20240425 FILED AS OF DATE: 20240314 DATE AS OF CHANGE: 20240314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 24748075 BUSINESS ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 BUSINESS PHONE: 2127332323 MAIL ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 DEF 14A 1 pfe-20240313.htm DEF 14A PFIZER PROXY pfe-20240313 0000078003 DEF 14A FALSE 0000078003 2023-01-01 2023-12-31 iso4217:USD 0000078003 2022-01-01 2022-12-31 0000078003 2021-01-01 2021-12-31 0000078003 2020-01-01 2020-12-31 0000078003 ecd:NonPeoNeoMember pfe:ProRataTargetBonusAwardMember 2023-01-01 2023-12-31 0000078003 1 2023-01-01 2023-12-31 0000078003 ecd:PeoMember pfe:StockAndOptionAwardsAdjustmentsMember 2023-01-01 2023-12-31 0000078003 ecd:PeoMember pfe:ChangeInPensionValueMember 2023-01-01 2023-12-31 0000078003 ecd:PeoMember 2023-01-01 2023-12-31 0000078003 ecd:PeoMember pfe:EquityAwardsGrantedDuringTheYearMember 2023-01-01 2023-12-31 0000078003 ecd:PeoMember pfe:EquityAwardsGrantedInPriorYearsUnvestedMember 2023-01-01 2023-12-31 0000078003 ecd:PeoMember pfe:EquityAwardsGrantedInPriorYearsVestedMember 2023-01-01 2023-12-31 0000078003 ecd:PeoMember pfe:StockAndOptionAwardsAdjustmentsMember 2022-01-01 2022-12-31 0000078003 ecd:PeoMember pfe:ChangeInPensionValueMember 2022-01-01 2022-12-31 0000078003 ecd:PeoMember 2022-01-01 2022-12-31 0000078003 ecd:PeoMember pfe:EquityAwardsGrantedDuringTheYearMember 2022-01-01 2022-12-31 0000078003 ecd:PeoMember pfe:EquityAwardsGrantedInPriorYearsUnvestedMember 2022-01-01 2022-12-31 0000078003 ecd:PeoMember pfe:EquityAwardsGrantedInPriorYearsVestedMember 2022-01-01 2022-12-31 0000078003 ecd:PeoMember pfe:StockAndOptionAwardsAdjustmentsMember 2021-01-01 2021-12-31 0000078003 ecd:PeoMember pfe:ChangeInPensionValueMember 2021-01-01 2021-12-31 0000078003 ecd:PeoMember 2021-01-01 2021-12-31 0000078003 ecd:PeoMember pfe:EquityAwardsGrantedDuringTheYearMember 2021-01-01 2021-12-31 0000078003 ecd:PeoMember pfe:EquityAwardsGrantedInPriorYearsUnvestedMember 2021-01-01 2021-12-31 0000078003 ecd:PeoMember pfe:EquityAwardsGrantedInPriorYearsVestedMember 2021-01-01 2021-12-31 0000078003 ecd:PeoMember pfe:StockAndOptionAwardsAdjustmentsMember 2020-01-01 2020-12-31 0000078003 ecd:PeoMember pfe:ChangeInPensionValueMember 2020-01-01 2020-12-31 0000078003 ecd:PeoMember 2020-01-01 2020-12-31 0000078003 ecd:PeoMember pfe:EquityAwardsGrantedDuringTheYearMember 2020-01-01 2020-12-31 0000078003 ecd:PeoMember pfe:EquityAwardsGrantedInPriorYearsUnvestedMember 2020-01-01 2020-12-31 0000078003 ecd:PeoMember pfe:EquityAwardsGrantedInPriorYearsVestedMember 2020-01-01 2020-12-31 0000078003 pfe:StockAndOptionAwardsAdjustmentsMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0000078003 ecd:NonPeoNeoMember pfe:ChangeInPensionValueMember 2023-01-01 2023-12-31 0000078003 ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0000078003 ecd:NonPeoNeoMember pfe:EquityAwardsGrantedDuringTheYearMember 2023-01-01 2023-12-31 0000078003 pfe:EquityAwardsGrantedInPriorYearsUnvestedMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0000078003 ecd:NonPeoNeoMember pfe:EquityAwardsGrantedInPriorYearsVestedMember 2023-01-01 2023-12-31 0000078003 pfe:StockAndOptionAwardsAdjustmentsMember ecd:NonPeoNeoMember 2022-01-01 2022-12-31 0000078003 ecd:NonPeoNeoMember pfe:ChangeInPensionValueMember 2022-01-01 2022-12-31

View on Read The Filing